The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members
Open accessAbstract
Mutations in the progranulin gene (GRN) are an important cause of frontotemporal lobar degeneration (FTLD) with ubiquitin and TAR DNA-binding protein 43 (TDP43)-positive pathology. The clinical presentation associated with GRN mutations is heterogeneous and may include clinical probable Alzheimer's disease. All GRN mutations identified thus far cause disease through a uniform disease mechanism, i.e. the loss of functional GRN or haploinsufficiency. To determine if expression of GRN in plasma could predict GRN mutation status and could be used as a biological marker, we optimized a GRN ELISA and studied plasma samples of a consecutive clinical FTLD series of 219 patients, 70 control individuals, 72 early-onset probable Alzheimer's disease patients and nine symptomatic and 18 asymptomatic relatives of GRN mutation families. All FTLD patients with GRN loss-of-function mutations showed significantly reduced levels of GRN in plasma to about one third of the levels observed in non-GRN carriers and control individuals (P < 0.001). No overlap in distributions of GRN levels was observed between the eight GRN loss-of-function mutation carriers (range: 53-94 ng/ml) and 191 non-GRN mutation carriers (range: 115-386 ng/ml). Similar low levels of GRN were identified in asymptomatic GRN mutation carriers. Importantly, ELISA analyses also identified one probable Alzheimer's disease patient (1.4%) carrying a loss-of-function mutation in GRN. Biochemical analyses further showed that the GRN ELISA only detects full-length GRN, no intermediate granulin fragments. This study demonstrates that using a GRN ELISA in plasma, pathogenic GRN mutations can be accurately detected in symptomatic and asymptomatic carriers. The approximately 75% reduction in full-length GRN, suggests an unbalanced GRN metabolism in loss-of-function mutation carriers whereby more GRN is processed into granulins. We propose that plasma GRN levels could be used as a reliable and inexpensive tool to identify all GRN mutation carriers in early-onset dementia populations and asymptomatic at-risk individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Self-citationMutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., et al. (2006) · Nature · doi:10.1038/nature05016 · Cited by 2,058
Self-citationCruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.-J., et al. (2006) · Nature · doi:10.1038/nature05017 · Cited by 1,512
Self-citationMcKhann, G. M. (2001) · Archives of Neurology · doi:10.1001/archneur.58.11.1803 · Cited by 1,472
The logopenic/phonological variant of primary progressive aphasia
Gorno-Tempini, M. L., Brambati, S. M., Ginex, V., Ogar, J., Dronkers, N. F., Marcone, A., Perani, D., Garibotto, V., Cappa, S. F., & Miller, B. L. (2008) · Neurology · doi:10.1212/01.wnl.0000320506.79811.da · Cited by 710
Conversion of Proepithelin to Epithelins
Zhu, J., Nathan, C., Jin, W., Sim, D., Ashcroft, G. S., Wahl, S. M., Lacomis, L., Erdjument-Bromage, H., Tempst, P., Wright, C. D., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01141-8 · Cited by 633
Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration
Gass, J., Cannon, A., Mackenzie, I. R., Boeve, B., Baker, M., Adamson, J., Crook, R., Melquist, S., Kuntz, K., Petersen, R., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl241 · Cited by 580
Self-citationProgranulin is a mediator of the wound response
He, Z., Ong, C. H. P., Halper, J., & Bateman, A. (2003) · Nature Medicine · doi:10.1038/nm816 · Cited by 490
He, Z., & Bateman, A. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0474-3 · Cited by 476
Primary Progressive Aphasia — A Language-Based Dementia
Mesulam, M.-M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022435 · Cited by 472
Van Damme, P., Van Hoecke, A., Lambrechts, D., Vanacker, P., Bogaert, E., van Swieten, J., Carmeliet, P., Van Den Bosch, L., & Robberecht, W. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200712039 · Cited by 418
Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration
Ghidoni, R., Benussi, L., Glionna, M., Franzoni, M., & Binetti, G. (2008) · Neurology · doi:10.1212/01.wnl.0000325058.10218.fc · Cited by 299
Granulins: the structure and function of an emerging family of growth factors
Bateman, A., & Bennett, H. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1580145 · Cited by 241
van Swieten, J. C., & Heutink, P. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70194-7 · Cited by 234
Beck, J., Rohrer, J. D., Campbell, T., Isaacs, A., Morrison, K. E., Goodall, E. F., Warrington, E. K., Stevens, J., Revesz, T., Holton, J., et al. (2008) · Brain · doi:10.1093/brain/awm320 · Cited by 230
Progranulin in frontotemporal lobar degeneration and neuroinflammation
Ahmed, Z., Mackenzie, I. R., Hutton, M. L., & Dickson, D. W. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-7 · Cited by 224
Self-citationRademakers, R., Baker, M., Gass, J., Adamson, J., Huey, E. D., Momeni, P., Spina, S., Coppola, G., Karydas, A. M., Stewart, H., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70221-1 · Cited by 216
Self-citationLipton, A. M., White, C. L., & Bigio, E. H. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0900-9 · Cited by 188
Mukherjee, O., Pastor, P., Cairns, N. J., Chakraverty, S., Kauwe, J. S. K., Shears, S., Behrens, M. I., Budde, J., Hinrichs, A. L., Norton, J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20963 · Cited by 187
Josephs, K. A., Ahmed, Z., Katsuse, O., Parisi, J. F., Boeve, B. F., Knopman, D. S., Petersen, R. C., Davies, P., Duara, R., Graff-Radford, N. R., et al. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31803020cf · Cited by 183
Self-citationProminent phenotypic variability associated with mutations in Progranulin
Kelley, B. J., Haidar, W., Boeve, B. F., Baker, M., Graff-Radford, N. R., Krefft, T., Frank, A. R., Jack, C. R., Shiung, M., Knopman, D. S., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.08.022 · Cited by 181
Self-citationGenetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease
Brouwers, N., Sleegers, K., Engelborghs, S., Maurer-Stroh, S., Gijselinck, I., van der Zee, J., Pickut, B. A., Van den Broeck, M., Mattheijssens, M., Peeters, K., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000319688.89790.7a · Cited by 166
Progranulin null mutations in both sporadic and familial frontotemporal dementia
Le Ber, I., van der Zee, J., Hannequin, D., Gijselinck, I., Campion, D., Puel, M., Laquerrière, A., De Pooter, T., Camuzat, A., Van den Broeck, M., et al. (2007) · Human Mutation · doi:10.1002/humu.20520 · Cited by 164
Progranulin Mutations in Primary Progressive Aphasia: The PPA1 and PPA3 Families
Mesulam, M., Johnson, N., Krefft, T. A., Gass, J. M., Cannon, A. D., Adamson, J. L., Bigio, E. H., Weintraub, S., Dickson, D. W., Hutton, M. L., et al. (2007) · Archives of Neurology · doi:10.1001/archneur.64.1.43 · Cited by 160
Self-citationFrontotemporal lobar degeneration and ubiquitin immunohistochemistry
Josephs, K., Holton, J., Rossor, M., Godbolt, A., Ozawa, T., Strand, K., Khan, N., Al-Sarraj, S., & Révész, T. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2003.00545.x · Cited by 156
Brouwers, N., Nuytemans, K., van der Zee, J., Gijselinck, I., Engelborghs, S., Theuns, J., Kumar‐Singh, S., Pickut, B. A., Pals, P., Dermaut, B., et al. (2007) · Archives of Neurology · doi:10.1001/archneur.64.10.1436 · Cited by 148
Gijselinck, I., Broeckhoven, C. V., & Cruts, M. (2008) · Human Mutation · doi:10.1002/humu.20785 · Cited by 137
A novel deletion in progranulin gene is associated with FTDP-17 and CBS
Benussi, L., Binetti, G. G., Sina, E., Gigola, L., Bettecken, T., Meitinger, T., & Ghidoni, R. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.10.028 · Cited by 125
Graff‐Radford, N. R., & Woodruff, B. K. (2007) · Seminars in Neurology · doi:10.1055/s-2006-956755 · Cited by 102
Self-citationMutations in progranulin explain atypical phenotypes with variants in MAPT
Pickering-Brown, S. M., Baker, M., Gass, J. M., Boeve, B. F., Loy, C. T., Brooks, W. S., Mackenzie, I. R., Martins, R. N., Kwok, J. B., Halliday, G. M., et al. (2006) · Brain · doi:10.1093/brain/awl289 · Cited by 99
Self-citationProgranulin locus deletion in frontotemporal dementia
Gijselinck, I., van der Zee, J., Engelborghs, S., Goossens, D., Peeters, K., Mattheijssens, M., Corsmit, E., Del‐Favero, J., Deyn, P. P. D., Broeckhoven, C. V., et al. (2007) · Human Mutation · doi:10.1002/humu.20651 · Cited by 94
Corticobasal Syndrome Associated With the A9D Progranulin Mutation
Spina, S., Murrell, J. R., Huey, E. D., Wassermann, E. M., Pietrini, P., Grafman, J. H., & Ghetti, B. F. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181567873 · Cited by 90
Gene expression study on peripheral blood identifies progranulin mutations
Coppola, G., Karydas, A., Rademakers, R., Wang, Q., Baker, M. C., Hutton, M., Miller, B. L., & Geschwind, D. H. (2008) · Annals of Neurology · doi:10.1002/ana.21397 · Cited by 90
Self-citationDementia lacking distinctive histology (DLDH) revisited
Mackenzie, I. R., Shi, J., Shaw, C. L., DuPlessis, D., Neary, D., Snowden, J. S., & Mann, D. M. A. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0123-3 · Cited by 90
Molecular characterization of novel progranulin ( GRN ) mutations in frontotemporal dementia
Mukherjee, O., Wang, J., Gitcho, M. A., Chakraverty, S., Taylor‐Reinwald, L., Shears, S., Kauwe, J. S. K., Norton, J. B., Levitch, D., Bigio, E. H., et al. (2008) · Human Mutation · doi:10.1002/humu.20681 · Cited by 85
Rovelet‐Lecrux, A., Deramecourt, V., Legallic, S., Maurage, C., Ber, I. L., Brice, A., Lambert, J., Frébourg, T., Hannequin, D., Pasquier, F., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.03.004 · Cited by 66
Self-citationNovel PSEN1 and PGRN mutations in early-onset familial frontotemporal dementia
Bernardi, L., Tomaino, C., Anfossi, M., Gallo, M., Geracitano, S., Costanzo, A., Colao, R., Puccio, G., Frangipane, F., Curcio, S. A. M., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.005 · Cited by 62
The genetics of frontotemporal lobar degeneration
Rademakers, R., & Hutton, M. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0067-6 · Cited by 51
Self-citationBoeve, B. F. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.04.002 · Cited by 33
Self-citation
Cited by
TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia
Mackenzie, I. R., Rademakers, R., & Neumann, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70195-2 · Cited by 975
Self-citationTREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
Kleinberger, G., Yamanishi, Y., Suárez-Calvet, M., Czirr, E., Lohmann, E., Cuyvers, E., Struyfs, H., Pettkus, N., Wenninger-Weinzierl, A., Mazaheri, F., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009093 · Cited by 798
Lui, H., Zhang, J., Makinson, S. R., Cahill, M. K., Kelley, K. W., Huang, H.-Y., Shang, Y., Oldham, M. C., Martens, L. H., Gao, F., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.001 · Cited by 729
Self-citationClinical, genetic and pathological heterogeneity of frontotemporal dementia: A review
Seelaar, H., Rohrer, J. D., Pijnenburg, Y. A. L., Fox, N. C., & van Swieten, J. C. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.212225 · Cited by 609
Sortilin-Mediated Endocytosis Determines Levels of the Frontotemporal Dementia Protein, Progranulin
Hu, F., Padukkavidana, T., Vægter, C. B., Brady, O. A., Zheng, Y., Mackenzie, I. R., Feldman, H. H., Nykjaer, A., & Strittmatter, S. M. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.034 · Cited by 536
Metadata
- Authors
- Finch, N., Baker, M., Crook, R., Swanson, K., Kuntz, K., Surtees, R., Bisceglio, G., Rovelet-Lecrux, A., Boeve, B., Petersen, R. C., Dickson, D. W., Younkin, S. G., Deramecourt, V., Crook, J., Graff-Radford, N. R., & Rademakers, R.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-01-21
- Volume
- 132
- Issue
- 3
- Pages
- 583-591
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2001811842
- Cited by
- 386
- References
- 42
- FWCI
- 18.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.